March 23, 2021

FXCM named Best Zero Commission Broker at ADVFN Awards 2021

LONDON and SYDNEY, Australia and JOHANNESBURG, South Africa, March 23, 2021 (GLOBE NEWSWIRE) — FXCM Group, LLC (‘FXCM Group’ or ‘FXCM’), the leading international provider of online foreign exchange trading, CFD trading and related services, announced today that they have been named the Best Zero Commission* Broker in the ADVFN

Zenas BioPharma Launches as a Cross-Border Biopharmaceutical Company to Bring Innovation to the Development and Delivery of Immune-Based Therapies

Lead product candidate, ZB001, has first-in-class potential in China for Thyroid Eye Disease Rapidly advancing seven pipeline programs, including three worldwide, with best-in-class potential in autoimmune and rare diseases Expanding a proven leadership team of veteran life science industry executives Company founded and initially funded by Tellus BioVentures and Fairmount

Lancement de Zenas BioPharma, société biopharmaceutique transfrontalière qui innove dans le développement et la fourniture de traitements immunitaires

Le produit candidat principal, ZB001, présente un potentiel de premier ordre en Chine pour les maladies de l’ophtalmopathie thyroïdienne Progression rapide de sept programmes de pipeline, dont trois dans le monde entier, avec un potentiel de premier ordre dans les maladies auto-immunes et rares Élargissement d’une équipe de direction avérée,

Recent Posts